Vise Technologies Inc. boosted its stake in Danaher Corporation (NYSE:DHR – Free Report) by 25.5% in the 3rd quarter, Holdings Channel reports. The firm owned 16,822 shares of the conglomerate’s stock after acquiring an additional 3,416 shares during the quarter. Vise Technologies Inc.’s holdings in Danaher were worth $3,727,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Prime Capital Investment Advisors LLC increased its position in shares of Danaher by 0.5% during the third quarter. Prime Capital Investment Advisors LLC now owns 9,203 shares of the conglomerate’s stock valued at $2,039,000 after buying an additional 45 shares during the period. Essential Investment Partners LLC boosted its position in shares of Danaher by 34.6% in the third quarter. Essential Investment Partners LLC now owns 175 shares of the conglomerate’s stock valued at $39,000 after acquiring an additional 45 shares during the period. Veery Capital LLC boosted its position in shares of Danaher by 3.1% in the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after acquiring an additional 48 shares during the period. Studio Investment Management LLC boosted its position in shares of Danaher by 3.3% in the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock valued at $302,000 after acquiring an additional 51 shares during the period. Finally, Meridian Financial Partners LLC grew its stake in Danaher by 1.2% during the third quarter. Meridian Financial Partners LLC now owns 4,636 shares of the conglomerate’s stock valued at $1,073,000 after acquiring an additional 56 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
NYSE:DHR opened at $229.99 on Wednesday. The stock has a market cap of $161.80 billion, a P/E ratio of 37.64, a PEG ratio of 2.86 and a beta of 0.76. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The business’s 50-day moving average price is $219.38 and its two-hundred day moving average price is $201.70. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. Danaher’s revenue was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.89 earnings per share. As a group, equities analysts predict that Danaher Corporation will post 8.59 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is currently 26.19%.
Wall Street Analysts Forecast Growth
DHR has been the topic of a number of analyst reports. Royal Bank Of Canada upped their target price on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Guggenheim raised their price target on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Robert W. Baird boosted their price target on shares of Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research report on Thursday, October 22nd. TD Cowen boosted their price target on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, October 22nd. Finally, Citigroup upped their price target on shares of Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $242.91.
Insider Transactions at Danaher
In other Danaher news, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 10.80% of the stock is currently owned by insiders.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.
The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.
Featured Stories
- Five stocks we like better than Danaher
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
